Supernus Pharmaceuticals, Inc. (SUPN)
45.42
-1.74
(-3.69%)
USD |
NASDAQ |
Dec 09, 16:00
45.42
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Shareholders Equity (Quarterly): 1.050B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.21B |
| BridgeBio Pharma, Inc. | -1.933B |
| CorMedix, Inc. | 374.13M |
| Assembly Biosciences, Inc. | 182.70M |
| Viking Therapeutics, Inc. | 713.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.420B |
| Total Liabilities (Quarterly) | 370.09M |
| Debt to Equity Ratio | 0.0402 |
| Current Ratio | 1.796 |
| Net Debt Paydown Yield | -0.02% |